0 results for 'Kite Pharma'
Pharmaceutical Legal and Regulatory Trends To Watch in 2024
This article highlights several notable legal and regulatory developments in 2023 and discusses developments that will continue to shape the pharmaceutical industry in 2024.Cancer Treatment Developer Hires Biotech Veteran for GC Role
Allogene's newly hired general counsel Earl Douglas said he was drawn to the South San Francisco-based company's "deep commitment to scientific innovation, experience and leadership."Cancer Treatment Developer Hires Biotech Veteran for GC Role
Allogene's newly hired general counsel Earl Douglas said he was drawn to the company's "deep commitment to scientific innovation, experience and leadership."4-Partner IP Litigation Team Decamps Milbank for Orrick in Southern California
Orrick has filled a gap in its IP litigation practice in the life sciences sector with a team, originally formed at Irell & Manella, that represents Genentech and Gilead Sciences.View more book results for the query "Kite Pharma"
Indian Law Blockbuster | $1.2 Billion Patent Denial | Judges, AKA Historians
The justices today hear the longest argument of this final week of the November argument session. We speak with Kathryn Fort, head of the ICWA appellate project at Michigan State University College of Law, the case.Mission Impossible? All-Star Lawyers Couldn't Convince Supreme Court in High-Stakes Case
Bristol-Myers Squibb had won a $1.2 billion judgment for infringement of its patent on a cancer treatment. But the justices left in place a Federal Circuit decision that invalidated the patent for failing to meet the Patent Act's written description requirement.'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket
The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case that originated in the Southern District of New York. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.'Suckers' and Showstoppers: Everyone's Watching the Supreme Court's 2022 IP Docket
The court kicks off Term 2022 with arguments next month in the Andy Warhol fair-use case. Multiple life science companies are also asking the court to take up their patent cases, while a case on trademark extraterritoriality appears destined for certiorari.Litigator of the Week Runners-Up and Shout Outs!
Our first runner-up this week is Josh Rosenkranz of Orrick, Herrington & Sutcliffe who scored a huge win for Gilead Sciences affiliate Kite Pharma at the Federal Circuit last week.Download Now
Download Now
Download Now
Download Now